Key facts
| Recalling firm | Philips Healthcare (Suzhou) Co., Ltd. |
|---|---|
| Manufacturer | Not disclosed in the FDA record. |
| Brand name | Not disclosed in the FDA record. |
| Product description | Incisive CT, model 728143 & 728144 running Software Version 5.0.0. |
| Classification | Class II |
| Recall number | Z-0640-2024 |
| Report date | Not disclosed in the FDA record. |
| Status | Ongoing |
| Reason for recall | Multiple software issues which have the potential to lead to misdiagnosis due to image artifacts or incorrect image orientation labels, or the need for a CT rescan. These include: 1. Artifacts may occur on perfusion images, 2. Orientation label reversed in 2D images, 3. Auto voice does not work during the cardiac scan, 4. Auto voice and operators voice are too quiet, patient cant hear, 5. Not all of the images are reconstructed in some cases, 6. No image displayed on the console monitor after enabling CCT Single Scan, 7. Ring artifact appears in 32x0.625 collimation of bone scan when soft tissue view is selected, 8. A design defect where the error couch motion signal of couch firmware causes couch to identify current position as target position in next protocol, and 9. calcium scoring study split into separate series after loading to ISP. |
What consumers should do
Facilities, clinicians, and consumers holding an affected unit or lot of Incisive CT, model 728143 & 728144 running Software Version 5.0.0. should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Philips Healthcare (Suzhou) Co., Ltd.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Philips Healthcare (Suzhou) Co., Ltd. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Philips Healthcare (Suzhou) Co., Ltd. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.
What this classification means
A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.
Philips Healthcare (Suzhou) Co., Ltd.’s FDA history
Argus HQ has recorded 2 total FDA actions tied to Philips Healthcare (Suzhou) Co., Ltd.: 0 warning letters, 2 recalls, 0 approval records, and 0 Form 483 inspection citations.
Frequently asked questions
- What is the current status of this recall?
- Status as recorded by FDA: Ongoing.
- Where can I verify this recall directly with FDA?
- The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.
- Is Incisive CT, model 728143 & 728144 running Software Version recalled?
- Yes. FDA lists a Class II recall by Philips Healthcare (Suzhou) Co., Ltd. for Incisive CT, model 728143 & 728144 running Software Version 5.0.0., reported 20240117, with status "Ongoing." FDA recall number: Z-0640-2024.
- What is the recall class for Philips Healthcare (Suzhou) Co., Ltd.'s recall?
- FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Know if this happens again — we'll email you.
Free. No spam, just recall alerts for what you tell us to watch.
Related enforcement actions
Full FDA history for Philips Healthcare (Suzhou) Co., Ltd.Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2024). Recall Record: Class II Recall: Incisive CT, model 728143 & 728144 running Software… by Philips Healthcare (Suzhou) Co., Ltd.. Digital Empire LLC. Retrieved from https://argushq.ai/recall/philips-healthcare-suzhou-z-0640-2024-2024-01-17
"Recall Record: Class II Recall: Incisive CT, model 728143 & 728144 running Software… by Philips Healthcare (Suzhou) Co., Ltd.." Argus HQ Research, Digital Empire LLC, 2024, argushq.ai/recall/philips-healthcare-suzhou-z-0640-2024-2024-01-17.
Argus HQ Research. "Recall Record: Class II Recall: Incisive CT, model 728143 & 728144 running Software… by Philips Healthcare (Suzhou) Co., Ltd.." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/recall/philips-healthcare-suzhou-z-0640-2024-2024-01-17.
@misc{argushq_argushq_ai_recall_philips_healthcare_suzhou_z_0640_2024_2024_01_17_2024,
title = {Recall Record: Class II Recall: Incisive CT, model 728143 & 728144 running Software… by Philips Healthcare (Suzhou) Co., Ltd.},
author = {{Argus HQ Research}},
year = {2024},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/recall/philips-healthcare-suzhou-z-0640-2024-2024-01-17},
note = {Accessed: July 17, 2026}
}Source: FDA.gov — Recalls ↗